AtriCure (ATRC) Reports In-Line Q3 EPS; Guides FY15 Revenue Above Consensus
AtriCure (NASDAQ: ATRC) reported Q3 EPS of ($0.22), in-line with the analyst estimate of ($0.22). Revenue for the quarter came in at $31.4 million versus the consensus estimate of $31.38 million.
AtriCure sees FY2015 revenue of $129.5-130.5 million, versus the consensus of $128.6 million.
For earnings history and earnings-related data on AtriCure (ATRC) click here.